HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Davood Bashash Selected Research

Neoplasm Metastasis (Metastasis)

12/2023An overview of extracellular matrix and its remodeling in the development of cancer and metastasis with a glance at therapeutic approaches.
12/2019Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.
6/2019TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition.
2/2012Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Davood Bashash Research Topics

Disease

73Neoplasms (Cancer)
04/2024 - 02/2012
17Acute Promyelocytic Leukemia
04/2023 - 02/2012
13Leukemia
07/2023 - 10/2016
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2023 - 03/2013
11Breast Neoplasms (Breast Cancer)
10/2023 - 10/2016
10Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
03/2022 - 10/2016
9COVID-19
08/2022 - 01/2020
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2023 - 01/2017
5Hematologic Neoplasms (Hematological Malignancy)
09/2022 - 03/2019
5Inflammation (Inflammations)
10/2021 - 01/2020
4Neoplasm Metastasis (Metastasis)
12/2023 - 02/2012
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2023 - 05/2020
3Infections
08/2023 - 01/2021
3Carcinogenesis
04/2023 - 01/2020
3Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 12/2019
2Esophageal Neoplasms (Esophageal Cancer)
01/2024 - 01/2022
2Stomach Neoplasms (Stomach Cancer)
07/2023 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2021
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2016
2Multiple Myeloma
11/2021 - 01/2019
2Rheumatoid Arthritis
01/2021 - 12/2020
2Carcinoma (Carcinomatosis)
01/2017 - 01/2017
1Lung Neoplasms (Lung Cancer)
04/2024
1Colorectal Neoplasms (Colorectal Cancer)
03/2024
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2024
1Hepatocellular Carcinoma (Hepatoma)
01/2024
1Brain Diseases (Brain Disorder)
08/2023
1Headache (Headaches)
08/2023
1Mpox (monkeypox)
08/2023
1Anorexia
08/2023
1Myalgia
08/2023
1Disease Progression
07/2023
1Anaplastic Thyroid Carcinoma
05/2023
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2023

Drug/Important Bio-Agent (IBA)

20Arsenic Trioxide (Trisenox)FDA Link
04/2023 - 02/2012
11Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2016
10NVP-BKM120IBA
03/2024 - 10/2016
10Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2017
8Telomerase (Telomerase Reverse Transcriptase)IBA
03/2019 - 03/2013
6Immune Checkpoint InhibitorsIBA
01/2024 - 10/2021
6idelalisibIBA
04/2023 - 01/2017
6Toll-Like Receptor 4IBA
01/2021 - 06/2019
5Pioglitazone (Actos)FDA Link
10/2023 - 01/2020
5Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 11/2016
5BIBR 1532IBA
09/2020 - 03/2013
4Phosphatidylinositols (Phosphatidylinositol)IBA
11/2023 - 12/2018
4Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2023 - 01/2019
4PanobinostatIBA
02/2022 - 01/2020
4MicroRNAs (MicroRNA)IBA
12/2021 - 02/2012
4Histone Deacetylases (Histone Deacetylase)IBA
11/2021 - 01/2020
4CytokinesIBA
06/2021 - 12/2019
4Vincristine (Oncovin)FDA LinkGeneric
03/2020 - 01/2019
4ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
01/2020 - 06/2019
3VaccinesIBA
04/2024 - 09/2022
3CyclinsIBA
05/2023 - 01/2019
3Caspase 3 (Caspase-3)IBA
03/2022 - 07/2017
3EnzymesIBA
11/2021 - 01/2020
3Histone Deacetylase InhibitorsIBA
11/2021 - 01/2020
3Messenger RNA (mRNA)IBA
10/2021 - 01/2018
3Tyrosine Kinase InhibitorsIBA
05/2021 - 05/2020
3Aprepitant (Emend)FDA Link
10/2018 - 11/2016
3MelatoninIBA
01/2018 - 10/2016
2Cancer VaccinesIBA
04/2024 - 10/2023
2Imatinib Mesylate (Gleevec)FDA Link
12/2023 - 01/2021
2Long Noncoding RNAIBA
08/2023 - 07/2023
2Protein Isoforms (Isoforms)IBA
04/2023 - 01/2017
2Annexin A5IBA
03/2022 - 01/2022
2Gentian Violet (Violet, Crystal)FDA Link
01/2022 - 09/2020
23- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
01/2022 - 01/2018
2Insulin (Novolin)FDA Link
11/2021 - 09/2020
2PPAR gammaIBA
11/2021 - 01/2021
2Transcription Factors (Transcription Factor)IBA
10/2021 - 01/2020
2SurvivinIBA
04/2021 - 01/2018
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021 - 01/2021
2carfilzomibIBA
01/2021 - 01/2019
24- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
01/2020 - 01/2019
2ErbB Receptors (EGF Receptor)IBA
08/2019 - 01/2017
2dacomitinibIBA
08/2019 - 01/2017
2Hormones (Hormone)IBA
01/2019 - 01/2018
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
10/2018 - 01/2018
2CaspasesIBA
01/2018 - 01/2017
1Cisplatin (Platino)FDA LinkGeneric
03/2024
1Inosine Triphosphate (ITP)IBA
02/2024
1sintilimabIBA
01/2024
1camrelizumabIBA
01/2024
1Peptide Hydrolases (Proteases)FDA Link
12/2023
1MTOR InhibitorsIBA
11/2023
1TOR Serine-Threonine KinasesIBA
11/2023
13- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
08/2023
1RNA (Ribonucleic Acid)IBA
08/2023
1pembrolizumabIBA
07/2023
1Sirtuin 1IBA
07/2023
1Free RadicalsIBA
07/2023
1Phosphotransferases (Kinase)IBA
05/2023
1abemaciclibIBA
05/2023
1AlpelisibIBA
05/2023
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2023

Therapy/Procedure

39Therapeutics
01/2024 - 01/2016
7Immunotherapy
10/2023 - 01/2021
5Drug Therapy (Chemotherapy)
01/2022 - 01/2017